June 19 (Reuters) - Vanda Pharmaceuticals ( VNDA ) said
on Wednesday that it has rejected takeover offers UK-based Cycle
Pharmaceutical and a revised bid from contract manufacturer
Future Pak, adding that both offers undervalue the U.S.
drugmaker.